Recent Press Releases

Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA

Represents First BLA Submission for a PCSK9 Inhibitor

THOUSAND OAKS, Calif., Aug.

Mylan's ANDA for Three Times Per Week Generic Copaxone(R) 40 mg/mL Accepted for Filing by FDA

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL...

More information needed on type 2 diabetes drug empagliflozin

More information needed on type 2 diabetes drug empagliflozin NICE has called for more evidence from Boehringer Ingelheim on its drug empagliflozin for treating type 2 diabetes in new draft guidance....

Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA

Momenta Pharmaceuticals MNTA, -1.92% today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for a three-times-a-week...

Moberg Pharma AB (Formerly known as Moberg Derma)'s Head Of U.S. Operations To Resign By End Of January 2015

Moberg Pharma AB (Formerly known as Moberg Derma)'s Head Of U.S. Operations To Resign By End Of January 2015 STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Moberg Pharma AB (MOB.ST) today announced...

FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure

THOUSAND OAKS, Calif., Aug. 27, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the U.S.

Sanofi Appoints Jez Moulding to the Position of President, North America Pharmaceuticals

Sanofi Appoints Jez Moulding to the Position of President, North America Pharmaceuticals Bridgewater, N.J. – August 27, 2014 – Sanofi (EURONEXT: SAN and NYSE: SNY) today announced the...

GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)

GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive...

Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws

Announces Date for Special Meeting of Stockholders IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc. (NYSE: AGN) ("Allergan" or the "Company") announced today that it has asked...

New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S. pharmacies

New JARDIANCE Simple Savings program currently offered in doctors' offices and online

RIDGEFIELD, Conn. and

NAFTA Tribunal Decision Supports FDA and Its Actions

NAFTA Tribunal Decision Supports FDA and Its Actions TORONTO, Aug. 26, 2014 /PRNewswire/ - Apotex Inc., the largest Canadian owned pharmaceutical company, announced today that an arbitration tribunal...

Pfizer and Merck to Collaborate on Study Evaluating Novel Anti-Cancer Combination Regimen

Pfizer and Merck to Collaborate on Study Evaluating Novel Anti-Cancer Combination Regimen Agreement to Combine Merck's Investigational Anti-PD-1 Antibody Pembrolizumab and Pfizer's crizotinib...

Valeant Canada acquires Valeo Pharma's portfolio

Valeant Canada acquires Valeo Pharma's portfolio The pharmaceutical company consolidates its leadership position in dermatology in Canada LAVAL, QC, Aug. 25, 2014 /CNW Telbec/ - Valeant Canada...

Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay

Robust antibody gives researchers early access to PD-L1 and immunotherapy tissue staining for Research Use Only (RUO) applications

PLEASA

Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection

Multimedia assets associated with the below announcement are now available. Assets include: b-roll footage, corporate sound bites, product images and additional information.

Moody's: Indian pharmaceutical sector to see strong growth

Moody's: Indian pharmaceutical sector to see strong growth Singapore, August 25, 2014 -- Moody's Investors Service says that India's pharmaceutical market will continue to grow in the...

Iroko Pharmaceuticals Gains FDA Approval of ZORVOLEX® for Management of Osteoarthritis Pain

Iroko Pharmaceuticals Gains FDA Approval of ZORVOLEX® for Management of Osteoarthritis Pain New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA,...